Samer Al Hadidi

Oct 15, 2024 | nature.com | Ghulam Rehman Mohyuddin |Rajshekhar Chakraborty |Samer Al Hadidi

Dear Editor,Humans rely on heuristics to simplify decision-making [1] and often use chronological age as a key factor. However, chronological age may not accurately reflect an individual’s physiological age and functional performance [2]. A notable heuristic in decision-making is left-digit bias, where humans tend to categorize decisions based on the left-most digit of a continuous variable (e.g., age, blood pressure) [3].

May 30, 2024 | jamanetwork.com | Sonia Persaud |Samer Al Hadidi |Timothy Anderson |Grace Gallagher

Physicians commonly receive financial payments from industry, totaling $2.46 billion in 2022.1 These payments can represent scientific collaboration but may involve marketing efforts without scientific benefits, raising concerns regarding their influence on clinical decision-making.2 Pharmaceutical marketing frequently includes peer-to-peer promotion, often through speaking engagements.

Apr 9, 2024 | ejcancer.com | Samer Al Hadidi

The use of T-cell re-directing therapy in multiple myeloma (MM) is promising. [] Two chimeric antigen T cell receptor therapy (CAR-T) products: idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel) and three bispecific antibodies (BsAbs): (Teclistamab-cqyv, Talquetamab-tgvs, and Elranatamab-bcmm) are currently approved by the Food and Drug Administration (FDA) to use in relapsed/refractory (R/R) MM after receiving four or more prior lines of therapy.

Feb 14, 2024 | nature.com | Meera Mohan |Aniko Szabo |Samer Al Hadidi |Nirav Shah |Frits van Rhee |Mehdi Hamadani | +1 more

AbstractPersistent Immune Effector Cell Associated Hematotoxicity (ICAHT) is a significant side effect of BCMA CAR T-Cell therapy in patients with relapsed multiple myeloma (MM). The use of stem cell boosts in ICAHT has been described, however studies have been limited by small patient numbers and short follow up.

Feb 14, 2024 | healio.com | Josh Friedman |Mindy Valcarcel |Samer Al Hadidi

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].